Estazolam

Product manufactured by Actavis Pharma, Inc.

Application Nr Approved Date Route Status External Links
ANDA074818 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Estazolam Tablets, Usp Are Indicated For The Short-Term Management Of Insomnia Characterized By Difficulty In Falling Asleep, Frequent Nocturnal Awakenings, And/or Early Morning Awakenings. Both Outpatient Studies And A Sleep Laboratory Study Have Shown That Estazolam Administered At Bedtime Improved Sleep Induction And Sleep Maintenance (See Clinical Pharmacology ). Because Insomnia Is Often Transient And Intermittent, The Prolonged Administration Of Estazolam Is Generally Neither Necessary Nor Recommended. Since Insomnia May Be A Symptom Of Several Other Disorders, The Possibility That The Complaint May Be Related To A Condition For Which There Is A More Specific Treatment Should Be Considered. There Is Evidence To Support The Ability Of Estazolam To Enhance The Duration And Quality Of Sleep For Intervals Up To 12 Weeks (See Clinical Pharmacology ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Estazolam ESTAZOLAM ZINC1370

Comments